Zydus Lifesciences signs licensing deal with Formycon
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lifesciences will commercialise the product in the USA…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
From compliance to commitment: India Pharma Inc’s safety reckoning
A spate of fatal incidents at pharma plants has exposed critical gaps in workplace safety. With growing ESG scrutiny and global…
Pharma sector records higher deal value in November 2025
GlobalData data shows increases in mergers, acquisitions and venture funding activity year-on-year
Immutep and Dr Reddy’s enter Exclusive Licensing Agreement for Eftilagimod Alfa
Deal covers commercialisation and development rights outside key regulated markets
Anuh Pharma receives Certificate of Suitability from EDQM for Sulfadimethoxine
Company shares regulatory milestone and product details
Satya Karm Punia joins Putin’s India visit as part of official business delegation
Indian-origin pharma leader represented Russia in bilateral trade discussions
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
Company expands presence in Southeast Asia with new regulatory clearances
Lupin receives tentative U.S. FDA approval for Siponimod Tablets
Approval covers 0.25 mg, 1 mg and 2 mg strengths for multiple sclerosis treatment
Medley launches Biscal D –Calcium and Vitamin D3 fortified biscuit
Medley expands nutraceutical portfolio with fortified biscuit offering
Lupin signs exclusive licensing agreement with Valorum Biologics for Armlupeg in the U.S.
Companies outline roles in manufacturing, commercialisation and distribution
Granules India reports completion of FDA inspection with zero observations
Granules India outlines the inspection outcome and operational role of its U.S. subsidiary
Urgent reforms to ensure safe medicines: Need of the hour
Dr Suresh Saravdekar, former Assistant Director, Ministry of Medical Education and Health, State of Maharashtra, and Honorary…
India pharma and healthcare funding reaches $38.6 million in November 2025
Early-stage deals account for majority of investment activity
Corona Remedies announces IPO opening on 8 December 2025
Price band set at ₹1,008–₹1,062 per equity share
Cipla launches Ciplostem cell therapy for Knee Osteoarthritis in India
DCGI approval marks Cipla’s entry into orthobiologic medicine
Merck announces winners of the Merck Young Scientist Award 2025
Fourth edition recognises researchers across chemical and biological sciences categories
Green Pharma: How the industry can reduce its carbon footprint without compromising growth
Dr Supriya Shidhaye outlines how the pharma industry can shrink emissions while maintaining output and market expansion
SPARC wins U.S. court ruling on Sezaby Priority Review Voucher
U.S. District Court grants summary judgment in SPARC’s favour on Sezaby-linked voucher
Innovation made in India
As the world closes its doors and builds walls, India can chart its own course by leading the next wave of affordable, accessible…
Biocon Biologics reaches settlement with Amgen for Denosumab biosimilars commercialisation
Agreement enables Europe launch of Vevzuo and Evfraxy from December 2025